• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Keryx Biopharmaceuticals Inc

+ Add to Watchlist


15.1500 USD 0.2900 1.95%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Keryx Biopharmaceuticals Inc (KERX)

Open: 15.2100 Day's Range: 14.9000 - 15.3000 Volume: 1,582,098
Previous Close: 14.8600 52wk Range: 8.2900 - 17.4600 1-Yr Rtn: +65.03%

Stock Chart for KERX

No chart data available.
  • KERX:US 15.1500
  • 1D
  • 1M
  • 1Y
Interactive KERX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KERX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6900
Est. EPS (USD) (12/2014) -0.7840
Est. PEG Ratio -
Market Cap (M USD) 1,385.51
Shares Outstanding (M) 91.45
30 Day Average Volume 1,510,737
Price/Book (mrq) 9.6065
Price/Sale (ttm) 134.1039
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KERX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for KERX

Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.

Ron BentsurChief Executive OfficerJames F OlivieroCFO/Treasurer/Secretary
Gregory P Madison "Greg"Exec VP/COOBrian R AdamsVP/General Counsel
More Company Profile & Key Executives for KERX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil